← Leaderboards
Lore Gruenbaum
Applied Biomath, Llc
$932,611
Attributed
$932,611
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $744.2K · FY2017–18$1M$750K$500K$250K$0
'17
'18
Funding mix
By agency
NIH$932,611 · 1
By mechanism
R44$932,611 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposAmyloid Beta-ProteinClinical Decision-MakingAutosomal Dominant MutationBeta-Site App Cleaving Enzyme 1BindingBiologicalBiological MarkersBiologyBiotechnologyBrainBrain ImagingClinical BiomarkersClinical DataAreaClinical PathwaysClinical PharmacologyClinical PredictorsClinical ResearchClinical TrialsClinical Trials DesignCombined Modality TherapyComputer SimulationAmerican
Grant awards (2)
Development of a robust quantitative systems pharmacology model of amyloid beta and tau pathways for clinical trial design and decision making in Alzheimerâs Disease and Dementia.$744,248
R44 · FY2018 · AG · contact PI
Development of a robust quantitative systems pharmacology model of amyloid beta and tau pathways for clinical trial design and decision making in Alzheimerâs Disease and Dementia.$188,363
R44 · FY2017 · AG · contact PI